Home
About
FAQ
History (8)
Skeletal muscle pericyte subtypes differ in their differentiation potential.
Sustained overexpression of IGF-1 prevents age-dependent decrease in charge movement and intracellular Ca(2+) in mouse skeletal muscle.
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction.
Equating topical treatment of severe psoriasis to keeping money in a mattress.
New treatments for psoriasis: which biologic is best?
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New treatments for psoriasis: which biologic is best?
Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. New treatments for psoriasis: which biologic is best? J Dermatolog Treat. 2006; 17(2):96-107.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Cost-Benefit Analysis
Dermatologic Agents
Humans
Immunoglobulin G
Immunologic Factors
Injections
Psoriasis
Receptors, Tumor Necrosis Factor
Recombinant Fusion Proteins
United States
authors with profiles
Steven R. Feldman MD, PhD